 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C28H35NO4 |
| Molar mass | 449.591 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Asoprisnil (INN; developmental code nameJ-867) is asynthetic,steroidalselective progesterone receptor modulator that was under development bySchering andTAP Pharmaceutical Products for the treatment ofuterine fibroids.[1] In 2005,phase IIIclinical trials were discontinued due toendometrial changes in patients.[2]
 | Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byadding missing information. |
